Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-27T12:10:10.664Z Has data issue: false hasContentIssue false

Molecular mechanisms triggered by low-calcium diets

Published online by Cambridge University Press:  19 October 2009

Viviana Centeno
Affiliation:
Laboratorio de Metabolismo Fosfocálcico y Vitamina D ‘Dr. F. Cañas’, Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina
Gabriela Díaz de Barboza
Affiliation:
Laboratorio de Metabolismo Fosfocálcico y Vitamina D ‘Dr. F. Cañas’, Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina
Ana Marchionatti
Affiliation:
Laboratorio de Metabolismo Fosfocálcico y Vitamina D ‘Dr. F. Cañas’, Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina
Valeria Rodríguez
Affiliation:
Laboratorio de Metabolismo Fosfocálcico y Vitamina D ‘Dr. F. Cañas’, Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina
Nori Tolosa de Talamoni*
Affiliation:
Laboratorio de Metabolismo Fosfocálcico y Vitamina D ‘Dr. F. Cañas’, Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina
*
*Corresponding author: Dr Nori Tolosa de Talamoni, fax +54 351 4333072,email ntolosa@biomed.uncor.edu
Rights & Permissions [Opens in a new window]

Abstract

Ca is not only essential for bone mineralisation, but also for regulation of extracellular and intracellular processes. When the Ca2+ intake is low, the efficiency of intestinal Ca2+ absorption and renal Ca2+ reabsorption is increased. This adaptive mechanism involves calcitriol enhancement via parathyroid hormone stimulation. Bone is also highly affected. Low Ca2+ intake is considered a risk factor for osteoporosis. Patients with renal lithiasis may be at higher risk of recurrence of stone formation when they have low Ca2+ intake. The role of dietary Ca2+ on the regulation of lipid metabolism and lipogenic genes in adipocytes might explain an inverse relationship between dairy intake and BMI. Dietary Ca2+ restriction produces impairment of the adipocyte apoptosis and dysregulation of glucocorticosteroid metabolism in the adipose tissue. An inverse relationship between hypertension and a low-Ca2+ diet has been described. Ca2+ facilitates weight loss and stimulates insulin sensitivity, which contributes to the decrease in the blood pressure. There is also evidence that dietary Ca2+ is associated with colorectal cancer. Dietary Ca2+ could alter the ratio of faecal bile acids, reducing the cytotoxicity of faecal water, or it could activate Ca2+-sensing receptors, triggering intracellular signalling pathways. Also it could bind luminal antigens, transporting them into mucosal mononuclear cells as a mechanism of immunosurveillance and promotion of tolerance. Data relative to nutritional Ca2+ and incidences of other human cancers are controversial. Health professionals should be aware of these nutritional complications and reinforce the dairy intakes to ensure the recommended Ca2+ requirements and prevent diseases.

Type
Review Article
Copyright
Copyright © The Authors 2009

Introduction

Ca is a fundamental building block of bone and, hence, is essential for achieving optimal peak bone mass in the first two to three decades of life and for the maintenance of bone mass, later in life(Reference Ma, Johns and Stafford1). It is also important for many physiological processes such as nerve impulse transmission, muscle contraction, blood coagulation, secretory activity and apoptosis(Reference Petre-Lazar, Livera and Moreno2, Reference Li, Kondo and Zhao3). The dysregulation of Ca homeostasis appears to be a common factor linking conditions such as hypertension, insulin resistance and obesity(Reference Zemel4). Although some epidemiological studies have shown an inverse association between dietary Ca2+ and risk of breast and colon cancer, in prostate cancer, a high Ca2+ intake has been associated with higher risk(Reference McCullough, Rodriguez and Diver5Reference Lipkin8). As the diet is the only external source of Ca2+, appropriate levels of the mineral intake according to age and sex are recommended, in order to preserve bone health and metabolic balance. These requirements are higher in childhood, pregnancy and lactation. The intake of dairy products and Ca2+ supplements has been highly advertised for many years. However, most of the studies show that Ca2+ intake is much lower than the international recommendations in the majority of countries(Reference Kranz, Lin and Wagstaff9Reference Gilis-Januszewska, Topór-Madry and Pajak11), with a few exceptions such as Finland and Denmark(Reference Lyytikäinen, Lamberg-Allardt and Kannas12, Reference Olsen, Dragsted and Hansen13). Although adaptive mechanisms have evolved to control the amount of Ca2+ that is absorbed, the efficiency of this response involves metabolic changes, whose persistence with time may be deleterious.

Effect of dietary Ca2+ deficiency on Ca2+ homeostasis and the metabolism of calciotropic hormones

Dietary Ca2+ deficiency provokes increments in the efficiency of intestinal Ca2+ absorption and in renal Ca2+ reabsorption(Reference Bhatia14). This is an adaptation process performed as a compensation mechanism in order to cover the cation needs of the organism(Reference Pérez, Ulla and García15). Serum Ca2+ levels may be normal or low, according to the extent and degree of Ca2+ deficiency. We have demonstrated hypocalcaemia in chicks after 10 d of low Ca2+ intake (0·1%)(Reference Tolosa de Talamoni16, Reference Centeno, Díaz de Barboza and Marchionatti17). The mechanisms of adaptation to low-Ca2+ diets depend on the vitamin D status, mainly of the rate of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) synthesis. Cholecalciferol is hydroxylated in two steps: the first hydroxylation occurs at the carbon at the 25 position in the liver, and the second hydroxylation takes place in the kidney at the level of the carbon at the 1 position(Reference Tolosa de Talamoni and Centeno18). An increase in the serum levels of 1,25(OH)2D3 by a low-Ca2+ diet has been shown in human subjects(Reference O'Brien, Abrams and Liang19), chicks(Reference Swaminathan, Sommerville and Care20), ewes(Reference Hanley, Takatsuki and Birnbaumer21) and rats(Reference Hughes, Brumbaugh and Hussler22), but not in hamsters(Reference Schedl, Conway and Horst23). On the contrary, dietary Ca2+ restriction in the presence of constant vitamin D intake may cause depletion of 25-hydroxycholecalciferol, as shown in the plasma of rats as a consequence of high activity of the renal enzyme 25-OH-cholecalciferol 1-hydroxylase (CYP27B1), which catalyses the transformation of 25-hydroxyvitamin D3 (25OHD3) into 1,25(OH)2D3(Reference Vieth, Fraser and Kooh24). In renal stone formers, identified as absorptive hypercalciuric or renal hypercalciuric, Gascon-Barré et al. (Reference Gascon-Barré, D'Amour and Dufresne25) have observed lower circulating levels of 25OHD3 when they were on a low-Ca2+ diet as compared with those values shown with a normal-Ca2+ diet. CYP27B1 mRNA has been found to be expressed in the duodenum, the site of maximal vitamin D-regulated intestinal Ca2+ absorption(Reference Fleet, Gliniak and Zhang26), but at low levels relative to the kidney. Besides, it has been demonstrated that the intestinal enzyme is not altered by dietary Ca2+ restriction, which is the classical condition regulating the renal CYP27B1(Reference Fleet, Gliniak and Zhang26). High levels of 1,25(OH)2D3, caused by low-Ca2+ diets, modulate the adaptive changes in intestinal Ca2+ absorption and in renal Ca2+ reabsorption, apparently through vitamin D-mediated transcriptional activation(Reference Christakos, Dhawan and Liu27). An increment in the expression of proteins presumably involved in the Ca2+ movement through the cells has been reported, such as the Ca2+ channels Ca transport protein 1 (transient receptor potential cation channel, subfamily V, member 6; TRPV6) and Ca transport protein 2 (transient receptor potential cation channel, subfamily V, member 5; TRPV5)(Reference Brown, Krits and Armbrecht28), calbindin D9k, calbindin D28k(Reference Wasserman, Smith and Brindak29), Ca2+-ATPase or the Ca2+ pump(Reference Wasserman, Smith and Brindak29) and the Na+/Ca2+ exchanger(Reference Centeno, Díaz de Barboza and Marchionatti17).

The effect of low-Ca2+ diets on other metabolites derived from vitamin D is not well established. Fox et al. (Reference Fox, Bunker and Kamimura30) did not show an increase in 1,25(OH)2D3 catabolism, but they showed enhancement of the renal clearance of 1,25(OH)2D3. Goff et al. (Reference Goff, Reinhardt and Engstrom31) found a 6- to 20-fold increase in 24-hydroxylase (CYP24) activity in animals exposed to Ca2+-restricted diets as compared with those fed a Ca2+-replete diet.

Parathyroid hormone (PTH) secretion is also stimulated by low-Ca2+ diets(Reference Naveh-Many, Rahamimov and Livni32). Several studies have shown that the Ca-sensing receptor (CaR) of parathyroid cells is a key mediator of direct actions of extracellular Ca2+ on PTH secretion. CaR is a G protein-coupled receptor, whose activation by extracellular Ca2+ results in the suppression of PTH release(Reference Brown, Gamba and Riccardi33, Reference Chattopadhyay34). CaR was first identified in bovine parathyroid cells, and successively found in neurons, osteoblasts, keratinocytes, enterocytes and mammary epithelial cells. The sensitivity of parathyroid glands to small changes in serum Ca is remarkable. When hypocalcaemia is acute, the glands secrete PTH in a few seconds or minutes, this release being maintained between 60 and 90 min. A reduction in the intracellular PTH degradation also contributes to sustain this response. If hypocalcaemia is maintained for several hours or days, PTH gene expression is increased and if the same condition persists for several days or weeks, cellular proliferation in the glands is augmented(Reference Díaz, El-Hajj, Brown and Fray35). In rabbits, it has been found that 6 weeks of a low-Ca2+ diet produce parathyroid hyperplasia, characterised by increases in PTH secretion, glandular weight and proliferation and by a decrease in CaR mRNA(Reference Bas, Bas and López36). Brown(Reference Brown37) defined the set-point of the PTH secretion:Ca2+ levels ratio, which is the Ca concentration producing half of the maximal inhibition of secretion. This relationship has been useful in the analysis of PTH from patients with secondary hyperparathyroidism due to renal failure and in other conditions. Secondary hyperparathyroidism as well as dietary Ca2+ deprivation are characterised by an increase in parathyroid epithelial cell number. By using rats fed a low-Ca2+ diet for 8 weeks, it has been shown that endothelin-1 is significantly increased and bosentan, an endothelin-1 receptor antagonist, prevents any increase in the proliferation of parathyroid cells. Therefore, the blockage of endothelin receptors has been suggested to be an important strategy for preventing secondary hyperparathyroidism(Reference Kanesaka, Tokunaga and Iwashita38). Miao et al. (Reference Miao, Li and Xue39) have observed in PTH-deficient mice placed on a low-Ca2+ diet that renal CYP27B1 expression increases despite the absence of PTH, leading to an increase in serum 1,25(OH)2D3 levels, osteoclastogenesis, and a profound bone resorption. The authors think that although PTH is the first defence against hypocalcaemia, 1,25(OH)2D3 can be mobilised in the absence of PTH, to protect against an intense Ca2+ deficiency. Recently, it has been suggested that oestrogen is also necessary for the full adaptive response to a low-Ca2+ diet mediated by both PTH and 1,25(OH)2D3(Reference Zhang, Lai and Wu40).

Regarding calcitonin, another important calciotropic hormone, it has been shown that diets deficient in Ca2+ and vitamin D fed to weanling rats for 3 weeks do not change calcitonin mRNA levels, in contrast to the large increases in PTH mRNA levels. So, the authors conclude that calcitonin gene expression in vivo in the rat is not affected by changes in serum Ca2+(Reference Naveh-Many, Raue and Grauer41). The lack of studies on this issue makes it difficult to have a precise idea about the effect of Ca2+ deficiency on this hormone and its action.

Alteration of the intestinal function

Dietary Ca2+ deficiency exerts an important impact on the intestine and its function, mainly affecting the composition of intestinal plasma membranes and Ca2+ transport. Intestinal Ca2+ absorption seems to occur by two different mechanisms: transcellular and paracellular pathways. Both mechanisms are regulated by hormones, nutrients and other factors, which have been studied for many years due to their close relationship with osteoporosis and other disorders related to Ca2+ metabolism(Reference Pérez, Ulla and García15). The transcellular pathway comprises three steps: entry across the brush-border membrane, intracellular diffusion and exit through the basolateral membrane. As mentioned above, all the genes presumably involved in the transcellular pathway are enhanced by a low-Ca2+ diet, probably by activation of the vitamin D endocrine system(Reference Tolosa de Talamoni16, Reference Centeno, Díaz de Barboza and Marchionatti17, Reference Christakos, Dhawan and Liu27, Reference Brown, Krits and Armbrecht28). Furthermore, the enhancement in the activity and expression of the intestinal Ca2+ pump and the Na+/Ca2+ exchanger caused by Ca2+-deficient diets occurs either in mature or in undifferentiated enterocytes(Reference Centeno, Díaz de Barboza and Marchionatti17). However, vitamin D receptor (VDR) levels are decreased by low-Ca2+ diets. Ferrari et al. (Reference Ferrari, Bonjour and Rizzoli42) suggested that dietary Ca2+ deficiency might have a dual effect on VDR gene expression because homologous stimulation of VDR gene expression by calcitriol does not occur on a low-Ca2+ diet, as a result of a transcriptional suppression by a concomitant increase of PTH. In our laboratory, we found down-regulation of VDR expression by a low-Ca2+ diet, an effect that was independent of the degree of cell maturation(Reference Centeno, Díaz de Barboza and Marchionatti17). We think that high levels of serum 1,25(OH)2D3 caused by low-Ca2+ diets do not regulate the intestinal function by up-modulation of its nuclear receptor but promoting differentiation, which would produce cells more capable of expressing vitamin D-dependent genes required for Ca2+ absorption.

Other biochemical changes produced by low-Ca2+ diets in the intestine are related to the protein sulfhydryl groups and the lipid composition and fluidity of intestinal membranes. We have shown that the reactivity and availability of sulfhydryl groups from intestinal brush-border membrane proteins of chicks are increased by low-Ca2+ diets(Reference Tolosa de Talamoni, Mykkanen and Wasserman43). Although the functional significance of this response remains unknown, it is quite possible that the sulfhydryl status of the brush-border membrane proteins might be involved in the vitamin D-dependent intestinal Ca2+ absorption, as indicated by Mykkanen & Wasserman(Reference Mykkanen and Wasserman44). With regard to the lipid composition, we have shown minor changes in the fatty acid content of the intestinal basolateral membrane; however, lipid fluidity of diphenylhexatriene-labelled intestinal basolateral membrane from chicks is highly increased by the dietary Ca2+ restriction as compared with that from the control group(Reference Tolosa de Talamoni16). Thus, it appears that the Ca2+ exit through the basolateral membrane from the enterocytes in chicks adapted to a low-Ca2+ diet is greater than that from the control group; higher expression and activity of the Ca2+ pump and the Na+/Ca2+ exchanger and changes in lipid composition and fluidity, which could affect the microdomains of ion transporters, would be the mechanisms responsible for these adaptive responses of the intestine(Reference Tolosa de Talamoni and Centeno18). The activity of alkaline phosphatase, another candidate molecule to be involved in intestinal Ca2+ absorption, is highly increased in chicks by dietary Ca2+ restriction, either in mature or immature enterocytes(Reference Centeno, Díaz de Barboza and Marchionatti17). This could be a concomitant effect of higher levels of 1,25(OH)2D3 triggered by a low-Ca2+ diet, but a real role in intestinal Ca2+ absorption cannot be discarded.

Recent data showed that under low dietary Ca2+ conditions there was a 4·1-, 2·9- and 3·9-fold increase in Ca2+ transport in the duodenum of wild-type, TRPV6 knock-out (KO) and calbindin D9k KO mice, respectively. In the TRPV6/calbindin D9k double KO mice fed a low-Ca2+ diet there was a 2·1-fold increase in the duodenal Ca2+ transport. Therefore, this study shows that active intestinal Ca2+ transport occurs in the absence of TRPV6 and calbindin D9k, which challenges the dogma that both proteins are essential for vitamin D-induced active intestinal Ca2+ transport(Reference Benn, Ajibade and Porta45). The data would indicate that TRPV6 may not be the rate-limiting factor in the transcellular pathway or its function is partially compensated by an unknown factor. On the basis that insulin-like growth factor-1 (IGF-1) mRNA was significantly induced in the duodenum of double KO mice under low dietary Ca2+ conditions, it is possible to think that IGF-1 may be the factor that contributes to the increment in intestinal Ca2+ absorption.

Figure 1 shows a schematic representation of mechanisms triggered by dietary Ca2+ restriction on the intestine as has been described above.

Fig. 1 A diet poor in Ca2+ decreases serum Ca2+ levels, which can be accompanied by normal or low serum phosphate. Hypocalcaemia induces a high parathyroid hormone (PTH) secretion, which in turn promotes renal 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) synthesis. This hormone binds to vitamin D receptors (VDR) in the intestine triggering transient receptor potential cation channel, subfamily V, member 6 (TRPV6), calbindin D (CB), Ca2+ pump (PMCA1), Na+/Ca2+ exchanger (NCX1) and alkaline phosphatase synthesis. As a consequence, the efficiency of intestinal Ca absorption is enhanced. VDRE, vitamin D response element; RXR, retinoid X receptor.

Low-Ca2+ diets and bone

Bone is highly affected by nutritional Ca2+ deficiencies in different periods of life and under some physiological conditions or pharmacological treatments. Kalkwarf et al. (Reference Kalkwarf, Khoury and Lanphear46) have demonstrated that women with low Ca2+ intakes during childhood and adolescence have less bone mass later in life and a greater risk of fractures. Regarding puberty in experimental animals, bone accretion seems to be very influenced by Ca2+ deficiencies. Kasukawa et al. (Reference Kasukawa, Baylink and Wergedal47) have shown during 2 weeks of pubertal growth that wild-type mice increase femur bone mineral density (BMD) 35 and 7% when fed normal- or low-Ca2+ diets, respectively, which indicates that bone accretion is impaired during Ca2+ deficiency. Furthermore, these effects were exaggerated in IGF-1 KO mice. Ca2+ deficiency produced decreases in endosteal bone formation parameters and much greater enhancement in the resorbing surface of the endosteum and periosteum of the tibia from the IGF-1 KO mice as compared with the wild-type mice. Although the molecular mechanisms by which IGF-1 deficiency increases serum PTH levels are unknown, these alterations could partially explain the negative impact of the lack of IGF-1 on bone accretion. The anabolic effect of PTH is also altered by nutritional Ca2+ deficiency. Steiner et al. (Reference Steiner, Forrer and Kneissel48) have demonstrated that the anabolic effect of human PTH (1–38) in animal bone is blunted by a low-Ca2+ diet, which suggests that dietary Ca2+ intake is critical during PTH treatment. It has also been demonstrated in experimental animals that accelerated bone resorption, caused by low-Ca2+ diets, promotes the growth of breast cancer tumours implanted in bone, independently of PTH action(Reference Zheng, Zhou and Modzelewski49). High vitamin D3 intake does not prevent bone loss induced by dietary Ca2+ restriction, at least in growing rats and mice(Reference Fleet, Gliniak and Zhang26).

Lactation produces a transient loss of bone to provide adequate Ca2+ for milk production. A complete recovery of bone density in the post-weaning period occurs in adult mothers irrespective of dietary Ca2+ levels. However, adolescent mothers with low-Ca2+ diets recover bone loss, but the rate of bone accretion seems not to be sufficient to attain peak bone mass at maturity(Reference Bezerra, Mendonça and Lobato50). Furthermore, the Apa I, Bsm I and Taq I VDR gene polymorphisms are associated with bone mass and/or breast milk Ca2+ in lactating adolescents with low Ca2+ intakes. Those adolescent mothers carrying the genotypes aa and tt had a better bone status and those with the genotype bb had higher breast milk Ca2+(Reference Bezerra, Cabello and Mendonça51).

Adequate Ca2+ intake has been demonstrated to reduce bone loss in peri- and postmenopausal women and to reduce fractures in women older than 60 years of age. Due to the fact that there is no accurate test to determine Ca2+ deficiency, it is considered that women must meet the recommended Ca2+ intake levels(52). Although a low-Ca2+ diet has been considered as a risk factor for developing osteoporosis, a recent article reviewing several databases for low BMD or for bone loss in healthy men aged 50 years or older has found that dietary Ca2+ is a weak risk factor for low BMD(Reference Papaioannou, Kennedy and Ioannidis53). The interaction of dietary Ca2+ content and physical activity seems to be very important to determine adequate BMD. It has been found in Scottish women with low or medium Ca2+ intake that BMD was higher amongst the most active individuals(Reference Mavroeidi, Stewart and Reid54).

Alteration of the renal function

It is well known that low blood Ca2+ increases PTH levels, which act on the kidneys increasing Ca2+ reabsorption and 1,25(OH)2D3 production through the activation of CYP27B1(Reference Murayama, Takeyama and Kitanaka55). Overproduction of 1,25(OH)2D3 in the kidneys is regulated by CYP24, which inactivates calcitriol by hydroxylation of the side chain at the carbon at the 24 position(Reference Omdahl, Morris and May56). Anderson et al. (Reference Anderson, O'Loughlin and May57) have used the technique of real-time RT-PCR to determine mRNA for both enzymes in the kidneys from animals exposed to different dietary Ca2+ concentrations. The levels of CYP27B1 mRNA were highest in the animals fed a low-Ca2+ diet and, conversely, the CYP24 mRNA levels were highest in animals with higher Ca2+ intake. These authors did not find a correlation between PTH and renal CYP27B1 mRNA levels in animals fed a vitamin D-replete diet, which suggests that serum Ca2+ may regulate CYP27B1 directly in conditions of normal blood Ca2+ levels. Thus, the transcription of CYP27B1 in vivo seems to be enhanced by PTH only in hypocalcaemic rats, but not in normocalcaemic animals.

Endogenous production of 1,25(OH)2D3, induced by a low-Ca2+ diet, can raise hormone levels four or five times above normal values without suppression of CYP27B1(Reference Goff, Reinhardt and Engstrom31). A decrease in the renal VDR content, which drops to 20% of control after prolonged dietary Ca2+ deficiency, could explain this effect(Reference Kato, Takeyama and Kitanaka58). Bajwa et al. (Reference Bajwa, Horst and Beckman59) have determined the differences in renal cortex gene expression between rats fed a low-Ca2+ diet (0·02% Ca2+) and those fed a normal-Ca2+ diet (0·47% Ca2+) and treated with two sequential 1 μg doses of calcitriol, by using the GeneChip oligonucleotide microarray technology and real-time RT-PCR to confirm the data. CaR was unaffected whereas PTH receptor-1 was increased (1·8-fold) by the low-Ca2+ diet. In contrast, intracellular vitamin D-binding protein, VDR, calbindin D28k, osteopontin and 24-OHase were all low under the same mineral condition. As expected, the 1α-OHase gene was up-regulated by the low-Ca2+ diet. Surprisingly, the expression of secreted phosphoprotein-24 and the transcription factors such as cAMP response element binding protein (CREB) and GATA binding protein globin 1 transcription factor 1 (GATA-1) were increased by the low-Ca2+ diet. The authors hypothesised that the cAMP–protein kinase A pathway is a distinctive feature of low Ca2+ in response to increased PTH. As VDR decreases by a low-Ca2+ diet, epithelial cells of the proximal tubules become refractory to enhanced calcitriol synthesis.

Patients with renal lithiasis may be at higher risk of recurrence of stone formation when they have Ca2+ intakes below the RDA. Although the restriction of Ca2+ decreases urinary excretion of the cation, intestinal oxalate absorption increases and the formation of stones due to secondary hyperoxaluria is enhanced. Health professionals must be aware of this, mainly with female patients who may develop osteoporotic complications and bone fractures because of dietary Ca2+ deficiency(Reference Pizzato and Barros60). The response of the stone formers to low-Ca2+ diets seems to be dependent on BMD. Pasch et al. (Reference Pasch, Frey and Eisenberger61) have observed that when these patients have low lumbar BMD, they exhibit a blunted response of PTH release and an enhanced production of 1,25(OH)2D3 after a low-Ca2+ diet. On the contrary, when patients have high lumbar BMD, PTH levels are highly increased after a dietary Ca2+ restriction. The reason for a large concentration of 1,25(OH)2D3 in the absence of a PTH response to a low-Ca2+ diet in stone-former patients with low BMD has been assumed to be reminiscent of a dynamic bone disease. The authors speculate that these patients might have normal or exaggerated intestinal Ca absorption because of 1,25(OH)2D3 enhancement, but they are not able to deposit the extra Ca2+ into their bones due to the primary bone problem and, hence, calciuria increases, facilitating stone formation.

Relationship between dietary Ca2+ and lipid metabolism

As MacDonald says if asked about a link between milk intake and weight in the past, the likely conclusion was that dairy was ‘fattening’(Reference MacDonald62). However, with the pioneering work of Zemel(Reference Zemel63), it has been understood that an energy-restricted diet with the inclusion of at least three servings of dairy per d will help to attain the ideal weight. Mirmiran et al. (Reference Mirmiran, Azadbakht and Azizi64) have also shown that there is an inverse relationship between dairy intake and BMI. The role of dietary Ca2+ on the regulation of lipid metabolism and lipogenic genes in adipocytes constitutes the molecular basis that might explain the results of nutritional trials. Several years ago, it was found that Agouti, an obesity gene expressed in human adipocytes, produces a protein which stimulates Ca2+ influx and energy storage in human adipocytes by Ca2+-dependent stimulation of fatty acid synthase and inhibition of lipolysis(Reference Jones, Kim and Zemel65, Reference Xue, Moustaid and Wilkison66). Calcitriol treatment of human adipocytes has been proved to activate fatty acid synthase and to inhibit lipolysis in a similar way to that done by agouti protein in these cells(Reference Zemel, Shi and Greer67). Therefore, suppression of calcitriol with high-Ca2+ diets would produce an anti-obesity effect. In fact, this has been demonstrated in transgenic mice overexpressing Agouti in adipocytes under the control of the aP2 promoter, mimicking the human expression pattern. Those mice placed on a low-Ca2+–high-fat–high-sucrose diet for 6 weeks showed increases in adipocyte lipogenesis, decreases in lipolysis and increments in body weight and adipose tissue mass. All these responses were partially reversed by high-Ca2+ diets, the reversion being more successful with dairy sources of Ca2+ than with Ca2(PO4)3. In a recent review about Ca2+-related obesity research(Reference Major, Chaput and Ledoux68), the authors discussed the different milk or dairy components that contribute to the impact of dairy Ca2+ on body weight. First of all, milk proteins are more satiating than fat and carbohydrates and are often found to suppress appetite and intake. Proteins of whey and casein reduce food intake, and stimulate biomarkers of satiety including gastrointestinal hormones, insulin and amino acids. Peptides derived from whey and casein are inhibitors of the renin–angiotensin system; this can explain the inverse relationship between blood pressure and dietary Ca2+. Thus, dairy proteins in addition to Ca2+ content may have a role in glycaemic control and the metabolic syndrome.

Several pathologies associated with Ca2+ deficiency have shown an increase in intracellular Ca2+ concentration in the presence of a low serum Ca2+. This is referred to as the ‘calcium paradox’(Reference Fujita and Palmieri69). A possible explanation of this response would be that the increase of 1,25(OH)2D3, promoted by a low-Ca2+ diet, produces stimulation of Ca2+ influx in the cells, as shown by Zemel et al. (Reference Zemel, Shi and Greer67) in cultures of human adipocytes. This increase in intracellular Ca2+ concentration stimulates fat storage by the activation of fatty acid synthase and inhibition of lipolysis by the activation of phosphodiesterse 3B, which leads to a decrease in cAMP, reducing the ability of agonists to stimulate hormone-sensitive lipase(Reference Xue, Greenberg and Kraemer70).

Another mechanism triggered by low-Ca2+ diets is an impairment in adipocyte apoptosis, which is attributed to high levels of 1,25(OH)2D3. In contrast, mice fed high-Ca and/or high-dairy diets exhibit a marked enhancement in adipocyte apoptosis. This is apparently contrary to many published reports showing pro-apoptotic effects of calcitriol in other tissues(Reference Lambert, Young and Persons71, Reference Tolosa de Talamoni, Narvaez, Welsh, Puntarulo and Boveris72). Sun & Zemel(Reference Sun and Zemel73) attribute this discrepancy to dosing differences because the pro-apoptotic effects of calcitriol are as a result of employing supra-physiological concentrations of calcitriol ( ≥ 100 nm), while the anti-apoptotic effect of calcitriol on human adipocytes was observed with physiological concentrations. Furthermore, the anti-apoptotic effects, apparently due to suppression of uncoupling protein 2 expression, were reversed by pharmacological doses of calcitriol in human adipocytes(Reference Sun and Zemel73). It is of interest to note that adipocyte apoptosis has not been extensively studied. One of the main difficulties is that adipocytes have a very low nuclear:cytoplasmic ratio, which restricts the identification of apoptotic cells and comparisons of apoptotic rates(Reference Prins, Walker and Winterford74). Nevertheless, adipocyte apoptosis has been demonstrated to occur by leptin treatment, which would act through NF-κB activation and increased levels of PPARγ inducing transcription of pro-apoptotic factors(Reference Della-Fera, Qian and Baile75).

The dysregulation of glucocorticosteroid metabolism is another alteration that has been proposed to be triggered by low-Ca2+ diets in adipose tissue. Morris & Zemel(Reference Morris and Zemel76) have demonstrated an increase in 11-β-hydroxysteroid dehydrogenase type I activity in human adipocytes treated with 1,25(OH)2D3. This enzyme converts cortisone to active cortisol. Its expression is greater in visceral adipose tissue than in subcutaneous fat. Consequently, these authors propose that dietary Ca2+ restriction might contribute to visceral fat through an increment in cortisol production induced by 1,25(OH)2D3, in addition to the fatty acid synthase activation already mentioned. A strong inverse association between Ca2+ intake and abdominal adiposity (total abdominal fat, abdominal visceral fat, abdominal subcutaneous fat, waist circumference) was found in black men and white women of the HERITAGE (Health, Risk factors, exercise Training And Genetics) Family Study(Reference Loos, Rankinen and Leon77). A similar finding was reported for women of the Québec Family Study(Reference Jackmain, Doucet and Despres78). However, not all studies found an inverse association between Ca2+ intake and adiposity(Reference Barr79). Recently, Heiss et al. (Reference Heiss, Shaw and Carothers80) determined lean and fat mass by dual-energy X-ray absorptiometry (DXA) and defined abdominal fat as fat mass between the top of the iliac crest and L1 on the DXA scan in Caucasian postmenopausal women. They observed that there was a significant inverse relationship between Ca intake and percentage body fat and abdominal fat mass, but there was no significant correlation between Ca intake and BMI, fat mass, lean mass, waist circumference or waist:hip ratio. They found that total fat was greater in the low dairy intake group v. the high dairy intake group, but they did not find significant differences between the groups in other body composition variables.

Association between hypertension and dietary Ca2+ deficiency

The history that dietary Ca2+ might have a meaningful impact on blood pressure regulation started a long time ago(Reference Addison and Clark81, Reference Crawford, Gardner and Morris82). In the early 1980s, two publications by McCarron et al. (Reference McCarron, Morris and Cole83, Reference McCarron, Morris and Stanton84) showed that low-Ca2+ diets were associated with hypertension and that dietary Ca2+ consumption by US adults was inversely related to the possibility of developing hypertension. A meta-analysis of forty-two clinical trials demonstrated significant blood pressure reduction by increasing Ca2+ intake either in non-pregnant populations as well as pregnancy-induced hypertension and pre-eclampsia(Reference Bucher, Guyatt and Cook85). The anti-hypertensive effect of Ca2+ appears to be paradoxical because Ca2+ supplementation leads to a reduction in systolic and diastolic blood pressure(Reference Griffith, Guyatt and Cook86), whereas an increase of intracellular Ca2+ enhances vascular smooth muscle tone, peripheral vascular resistance and blood pressure. The protective effect of Ca2+ on blood pressure could be explained through the stimulation of the vitamin D endocrine system. Low-Ca2+ diets increase circulating levels of 1,25(OH)2D3, which stimulates Ca2+ influx into vascular smooth muscle cells, thereby increasing vascular tone and blood pressure. In contrast, high-Ca2+ diets reduce the stimulus for Ca2+ influx by suppressing 1,25(OH)2D3 production. Certain heterogeneity of response in blood pressure to dietary Ca2+ has been noted, salt-sensitive patients being those who have most consistently exhibited anti-hypertensive responses(Reference Resnick87, Reference Zemel88). The Dietary Approaches to Stop Hypertension (DASH) study has demonstrated that a food consumption pattern rich in low-fat dairy products and in fruits and vegetables produces hypotensive effects comparable with those found in pharmacological trials of mild hypertension(Reference Appel, Moore and Obarzanek89). This study tested the effects of dietary patterns rather than individual nutrients on blood pressure. The authors think that the inconsistency of data from different trials may result from analysing a single nutrient, which could produce small blood pressure-lowering effects. They showed that either in subjects with hypertension or in those without hypertension, the combined diet reduced blood pressure more than the fruits-and-vegetables or the control diets. Furthermore, the interaction between hypertensive status and diet was higher for systolic blood pressure than for diastolic blood pressure. Thus, adoption of the DASH combination diet might prevent or delay the initiation of drug therapy in individuals at the threshold for drug treatment. Recently, a large prospective cohort study of middle-aged and older women has shown an inverse association between low-fat dairy product intake and the subsequent risk of hypertension. This association was moderate and independent of other risk factors for hypertension, but it was not observed between high-fat dairy intake and the risk of hypertension(Reference Wang, Manson and Buring90). Previously, by using a validated semi-quantitative FFQ, Alonso et al. (Reference Alonso, Beunza and Delgado-Rodríguez91) had shown in Spanish adult men and women that the highest quintile of low-fat dairy consumption was associated with a reduction of 54% in the risk of hypertension, while high-fat dairy consumption was not associated with the incidence of hypertension. The reason for this remains unclear. High-fat dairy products might hinder Ca2+ absorption because Ca2+ forms soaps with the fatty acids, reducing the bioavailability of Ca2+. Another possibility is that changes in the nutritional composition of the skimmed milk and whole milk during processing and preparation (less amount of fat, loss of Ca2+ in soluble form, proteins and appearance of encrypted peptides with hypotensive potential)(Reference Vyas and Tong92, Reference FitzGerald, Murray and Walsh93) could explain the differences, but this has not been confirmed(Reference Wang, Manson and Buring90). Regarding molecular mechanisms, it has been shown that dietary Ca2+ may lower the activity of the renin–angiotensin system(Reference Weiss and Taylor94) and inhibit vascular smooth muscle cell constriction(Reference Ramón de Berrazueta95). Besides, Ca2+ facilitates weight loss(Reference Scholz-Ahrens and Schrezenmeir96) and stimulates insulin sensitivity(Reference Szollosi, Nenquin and Aguilar-Bryan97), which contribute to decreases in blood pressure.

It remains unclear whether the Ca2+ content alone or in combination with several components such as other minerals or proteins, peptides or amino acids are responsible for the anti-hypertensive effects of dairy products(Reference Scholz-Ahrens and Schrezenmeir96). High levels of Ca2+, K+ and Mg2+ seem to be favourable but data are not conclusive(Reference Myers and Champagne98). It is quite possible that interactions among different minerals present in milk or dairy products as well as additive effects of milk compounds on hypertension could explain the benefits of dietary patterns (DASH study) as compared with supplementations of isolated nutrients.

Nutritional Ca2+ and risk of colon, breast, prostate and ovarian cancer

Evidence that dietary Ca2+ is associated with colorectal cancer has come from case–control studies, prospective cohort studies and some clinical trials(Reference Ryan-Harshman and Aldoori99). Cohort studies have detected that milk and dairy products have a protective effect on colorectal cancer(Reference Ryan-Harshman and Aldoori99). The mechanisms involved in this effect would be a decrease in cell proliferation or promotion in cell differentiation(Reference Holt, Atillasoy and Gilman100). Three cohort studies demonstrated a modest effect of Ca2+ on colorectal cancer risk reduction(Reference McCullough, Robertson and Rodriguez101Reference Pietinen, Malila and Virtanen103). Another study demonstrated that high consumption of milk might reduce colon cancer risk, but not because of the Ca2+ and vitamin D content(Reference Järvinen, Knekt and Hakulinen104). Hofstad et al. (Reference Hofstad, Almendingen and Vatn105) have found that a 3-year intervention with Ca2+ and antioxidants had no effect on polyp growth, but it might have a protective effect in avoiding formation of new adenomas. Grau et al. (Reference Grau, Baron and Sandler106) have found that the combination of Ca2+ and vitamin D reduces the risk of colorectal adenomas. Case–control studies have produced contradictory data. Some of them have demonstrated that Ca2+ intake is associated with a reduced risk of colorectal cancer(Reference Marcus and Newcomb107, Reference Franceschi and Favero108), but others have not(Reference Levi, Pasche and Lucchini109, Reference Pritchard, Baron and Gerhardsson de Verdier110). Recent pooled analysis and epidemiological studies have demonstrated an inverse relationship between Ca2+ intake and colorectal cancer or adenoma risk(Reference Cho, Smith-Warner and Spiegelman111, Reference Park, Murphy and Wilkens112). Furthermore, randomised clinical trials have shown that Ca2+ supplementation reduces adenoma risk(Reference Wallace, Baron and Cole113, Reference Shaukat, Scouras and Schünemann114).

Induction of colonic hyperproliferation and expansion of an epithelial cell population containing atypical nuclei have been found in experimental animals such as rats and mice fed Western-style diets (high fat, low Ca2+, low vitamin D, low fibre)(Reference Bises, Bajna and Manhardt115). When this feeding was prolonged, markers of incipient tumorigenesis such as dysplastic lesions and focal hyperplasia appeared. Cyclo-oxygenase (Cox)-2 protein, an inducible enzyme that is frequently overexpressed in inflamed tissues and in colorectal cancer, has also been found to be enhanced by dietary Ca2+ deficiency, mainly in females(Reference Bises, Bajna and Manhardt115). Although the molecular mechanisms by which dietary Ca2+ influences colonic health remain unknown, Pele et al. (Reference Pele, Thoree and Mustafa116) propose three possibilities: (1) dietary Ca2+ could alter the ratio of faecal bile acids, decreasing the water-soluble bile acids and reducing the cytotoxicity of faecal water; (2) Ca3(PO4)2 particles could bind luminal antigens, transporting them into mucosal mononuclear cells as a mechanism of immunosurveillance and promotion of tolerance; and (3) dietary Ca2+ could activate CaR, triggering intracellular signalling pathways, among them proliferative and apoptotic pathways. Several pathways are activated by Ca2+ through CaR, including activation of the p38 mitogen-activated protein kinase cascade, promotion of E-cadherin (tumour suppressor) and suppression of β-catenin/T cell factor binding (a process that promotes a malignant phenotype)(Reference Hobson, Wright and Lee117, Reference Chakrabarty, Radjendirane and Appelman118).

Data relative to nutritional Ca2+ and incidences of human cancers of the breast, prostate and pancreas are also controversial(Reference Farrow and Davis119). In a large prospective study, a high intake of Ca2+ and low-fat dairy products was found to be associated with a moderately lower risk of developing postmenopausal breast cancer as compared with women with the lowest intake levels. Interestingly, supplemental Ca or higher levels of total Ca (diet plus supplements) or vitamin D were not related to overall breast cancer risk(Reference McCullough, Rodriguez and Diver5). Human mammary epithelial (HME) cells exhibit VDR and CYP27B1 and show growth inhibition after exposure to physiological doses of 25OHD3, which indicates that autocrine or paracrine vitamin D signalling is involved in the maintenance of differentiation and quiescence of the mammary epithelium(Reference Kemmis and Welsh120). Oncogenic transformations of HME cells through introduction of known oncogenes (SV40 T antigens and H-rasV12) were associated with a reduction in mRNA and protein levels of VDR and CYP27B1. In addition, the transformation was also found to be associated with a reduction in 1,25(OH)2D3 synthesis and in the cellular sensitivity to growth inhibition caused by either 1,25(OH)2D3 or 25OHD3. These changes indicate that disruption of the vitamin D signalling pathway occurs early in cancer development(Reference Kemmis and Welsh120). Although the mechanisms involved in breast carcinogenesis induced by low-Ca2+ diets remain unknown, it is quite possible that dietary Ca2+ deficiency causes a dysregulation in the vitamin D endocrine system, which may result in a reduction in the response of breast cells to calcitriol and a promotion of oncogenic transformation. Calcitriol synthesis is increased by a secondary hyperparathyroidism provoked by hypocalcaemia(Reference Naveh-Many, Rahamimov and Livni32) and the continuous high exposure of breast cells to calcitriol may reduce the sensitivity of cells to the hormone. This could be due, at least in part, to down-regulation of VDR expression. High levels of circulating PTH would promote bone resorption. Growth factors such as transforming growth factor β and IGF might be released from the bone matrix, promoting tumour growth(Reference Zheng, Zhou and Modzelewski49). The activation of proto-oncogenes and/or inactivation of tumour suppressor genes as local carcinogenic stimuli could also contribute to the initiation of transformation of normal breast cells into malignant breast cells. Further experiments are needed in order to know the mechanisms by which dietary Ca2+ deficiency could contribute to the early steps of breast cancer development. As mentioned above, the growth of breast cancer tumours implanted in bone was promoted in experimental animals with accelerated bone resorption caused by low-Ca2+ diets(Reference Zheng, Zhou and Modzelewski49).

Giovanucci et al. (Reference Giovannucci, Liu and Stampfer6) have found an association between high Ca2+ intake and a higher risk of high-grade prostate cancer (Gleason histological grade>7), but not with well-differentiated organ-confined cancers. However, neither the development nor progression of prostate tumours in mice was enhanced by high-Ca2+ diets(Reference Mordan-McCombs, Brown and Zinser121). Through a randomised controlled clinical trial, Baron et al. (Reference Baron, Beach and Wallace122) demonstrated that there was no increase in prostate cancer risk associated with Ca2+ supplements, and they raised the possibility that Ca2+ may instead lower the risk of this cancer. Recently, Torniainen et al. (Reference Torniainen, Hedelin and Autio123) showed some evidence for low-fat milk as a potential risk factor for prostate cancer in patients from Nordic countries. Bonjour et al. (Reference Bonjour, Chevalley and Fardellone124) concluded that the link between Ca2+ and the development of prostate cancer remains a hypothesis, which is not supported so far by clinical data.

Epidemiological studies indicate that low-Ca2+ diets are risk factors for pancreatic cancer(Reference Xue, Yang and Newmark125). However, two recent prospective cohort studies have demonstrated that the inverse relationship between Ca2+ intake and the risk for pancreatic cancer is attenuated by adjusting for vitamin D intake. In contrast, vitamin D consumption has a significant inverse relationship with pancreatic cancer risk(Reference Skinner, Michaud and Giovannucci126). Clinical characteristics of patients need to be carefully controlled in these studies. Stolzenberg-Solomon et al. (Reference Stolzenberg-Solomon, Vieth and Azad127) conducted a prospective nested case–control study in male Finnish smokers (aged 50–69 years at baseline) to test whether prediagnostic 25OHD3 concentrations were associated with lower pancreatic cancer risk. Contrary to their expectations, they found that subjects with higher vitamin D status had an increased pancreatic cancer risk. Recently, they did not confirm that strong association between 25OHD3 and pancreatic cancer, adjusting for smoking and BMI, but they found an association between low estimated annual residential solar UVB exposure and cancer risk(Reference Stolzenberg-Solomon, Hayes and Horst128).

The association between risk of ovarian cancer and milk or dairy food intake is not clear either. The disaccharide lactose, naturally present as a component of milk and dairy products, is hydrolysed by the intestinal lactase into glucose and galactose. It was thought that galactose levels could be related to the risk of ovarian cancer because high circulating galactose may impair ovarian feedback to the pituitary gland, increasing gonadotropin secretion, which may increase oestrogenic stimulation, resulting in proliferation of ovarian epithelium(Reference Cramer129). This has been named the galactose–gonadotropin hypothesis. However, several authors did not find any correlation between the risk of developing ovarian cancer and dairy food intake, daily galactose consumption or the prevalence of low activity of galactose-1-phosphate-uridyltransferase or lactase persistence(Reference Goodman, Wu and Tung130, Reference Kuokkanen, Butzow and Rasinperä131, Reference Fung, Risch and McLaughlin132). In a case–control study in Hawaii and Los Angeles to examine several dietary hypotheses related to the aetiology of ovarian cancer, it was found that the intake of low-fat milk, Ca2+ or lactose may reduce the risk of ovarian cancer(Reference Goodman, Wu and Tung130). An association between ovarian cancer risk and a high whole milk intake, but not low-fat dairy product intake, suggested that fat, and not galactose, was the component that increases the cancer risk(Reference Qin, Xu and Wang133). Contrarily, a cohort study on diet and cancer carried out in The Netherlands(Reference Mommers, Schouten and Goldbohm134) did not find an association between dairy products or lactose intake and ovarian cancer risk. A modest increase in the risk of ovarian cancer with lactose intake at the level of three or more glasses of milk per d was observed in a pooled analysis of twelve cohort studies(Reference Genkinger, Hunter and Spiegelman135). The authors of this study suggested that dairy product consumption in relation to ovarian cancer risk should be further examined. Based on considerations described above, a schematic representation of the main metabolic changes caused by low-Ca2+ diets is summarised in Fig. 2.

Fig. 2 Metabolic changes caused by low-Ca2+ diets on different organs and tissues. TRPV6, transient receptor potential cation channel, subfamily V, member 6; VDR, vitamin D receptor; PTH, parathyroid hormone; NP, normal phosphate; CYP27B1, 25-OH-cholecalciferol 1-hydroxylase; 1,25(OH)2D3, 1,25-dihydroxyvitamin D3.

Concluding remarks

Although low-Ca2+ diets trigger adaptive mechanisms in order to maintain extracellular Ca2+ concentration and ensure Ca2+-dependent cellular functions, they also alter many metabolic pathways, whose persistence may lead to pathological conditions. The efficiency of intestinal Ca2+ absorption is increased due to the increment in renal calcitriol synthesis induced mainly by high levels of serum PTH. This calciotropic hormone promotes bone loss and, when Ca2+ deficiency occurs in childhood and adolescence, the attainability of peak bone mass is not reached. The association of low-Ca2+ diets with osteoporosis development is very weak, but, apparently, interactions between nutritional Ca2+ and vitamin D with physical activity seem to be important along the lifespan either to increase peak bone mass or to delay bone loss in the elderly. Lipid metabolism and lipogenic genes are altered in adipocytes as well as cortisol production, which might contribute to increased visceral fat. Circulating levels of 1,25(OH)2D3 stimulate Ca2+ influx into vascular smooth muscle cells, thereby increasing vascular tone and blood pressure. Proliferative and apoptotic pathways might be dysregulated, leading to the development and progression of malignancies such as colon, breast, prostate and ovarian cancers. Health professionals should be aware of these nutritional complications and reinforce the dairy intakes in individuals of all ages to ensure the recommended Ca2+ requirements and prevent diseases associated with poor Ca2+ intake.

Acknowledgements

N. T. de T. is a member of the Investigator Career from the Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET). V. C. is a postdoctoral fellow from Secretaría de Ciencia y Técnica de la Universidad Nacional de Córdoba (SECYT-UNC). V. R. is a doctoral fellow from CONICET.

The present study was supported by Fondo para la Investigación Científica y Tecnológica (FONCyT; PICT 2005-32464), CONICET (PIP 2005-6) and SECYT-UNC, all in Argentina.

Each author has contributed to literature searching, information analysis, discussion and writing of the present paper.

There are no conflicts of interest.

References

1Ma, J, Johns, RA & Stafford, RS (2007) Americans are not meeting current calcium recommendations. Am J Clin Nutr 85, 13611366.CrossRefGoogle Scholar
2Petre-Lazar, B, Livera, G, Moreno, SG, et al. . (2007) The role of p63 in germ cell apoptosis in the developing testis. J Cell Physiol 210, 8798.CrossRefGoogle ScholarPubMed
3Li, M, Kondo, T, Zhao, QL, et al. . (2000) Apoptosis induced by cadmium in human lymphoma U937 cells through Ca2+-calpain and caspase-mitochondria-dependent pathways. J Biol Chem 275, 3970239709.CrossRefGoogle ScholarPubMed
4Zemel, MB (2001) Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 20, 428S435S.CrossRefGoogle ScholarPubMed
5McCullough, ML, Rodriguez, C, Diver, WR, et al. . (2005) Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 14, 28982904.CrossRefGoogle ScholarPubMed
6Giovannucci, E, Liu, Y, Stampfer, MJ, et al. . (2006) A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 15, 203210.CrossRefGoogle ScholarPubMed
7Huncharek, M, Muscat, J & Kupelnick, B (2009) Colorectal cancer risk and dietary intake of calcium, vitamin D and dairy products: a meta-analysis of 26 335 cases from 60 observational studies. Nutr Cancer 61, 4769.CrossRefGoogle Scholar
8Lipkin, M (1999) Preclinical and early human studies of calcium and colon cancer prevention. Ann N Y Acad Sci 889, 120127.CrossRefGoogle ScholarPubMed
9Kranz, S, Lin, PJ & Wagstaff, DA (2007) Children's dairy intake in the United States: too little, too fat? J Pedriatr 151, 642646.CrossRefGoogle ScholarPubMed
10Ulla, M, Perez, A, Elias, V, et al. . (2007) Genotypes of vitamin D and estrogen receptors in pre and perimenopausal women from Cordoba, Argentina. Medicina 67, 3238.Google ScholarPubMed
11Gilis-Januszewska, A, Topór-Madry, R & Pajak, A (2003) Education and the quality of diet in women and men at age 45–64, in Cracow. Przegl Lek 60, 675681.Google ScholarPubMed
12Lyytikäinen, A, Lamberg-Allardt, C, Kannas, L, et al. . (2005) Food consumption and nutrient intakes with a special focus on milk product consumption in early pubertal girls in Central Finland. Public Health Nutr 8, 284289.CrossRefGoogle ScholarPubMed
13Olsen, SF, Dragsted, LO, Hansen, HS, et al. . (2005) The scientific basis of current official dietary recommendations in relation to pregnancy. Ugeskr Laeger 167, 27822784.Google ScholarPubMed
14Bhatia, V (2008) Dietary calcium intake – a critical reappraisal. Indian J Med Res 127, 269273.Google ScholarPubMed
15Pérez, A, Ulla, M, García, B, et al. . (2008) Genotypes and clinical aspects associated with bone mineral density in Argentine postmenopausal women. J Bone Miner Metab 26, 358365.CrossRefGoogle ScholarPubMed
16Tolosa de Talamoni, NG (1996) Calcium and phosphorous deficiencies alter the lipid composition and fluidity of intestinal basolateral membranes. Comp Biochem Physiol A Physiol 115, 309315.CrossRefGoogle ScholarPubMed
17Centeno, VA, Díaz de Barboza, GE, Marchionatti, AM, et al. . (2004) Dietary calcium deficiency increases Ca2+ uptake and Ca2+ extrusion mechanisms in chick enterocytes. Comp Biochem Physiol A Mol Integr Physiol 139, 133141.CrossRefGoogle ScholarPubMed
18Tolosa de Talamoni, N & Centeno, V (1999) Low calcium diets in humans and in experimental animals: classic models to understand calcium homeostasis and vitamin D endocrine systems. Endocrinologia 46, 241244.Google Scholar
19O'Brien, KO, Abrams, SA, Liang, LK, et al. . (1996) Increased efficiency of calcium absorption during short periods of inadequate calcium intake in girls. Am J Clin Nutr 63, 579583.CrossRefGoogle ScholarPubMed
20Swaminathan, R, Sommerville, BA & Care, AD (1977) The effect of dietary calcium on the activity of 25-hydroxycholecalciferol-1-hydroxylase and Ca absorption in vitamin D-replete chicks. Br J Nutr 38, 4754.CrossRefGoogle ScholarPubMed
21Hanley, DA, Takatsuki, K, Birnbaumer, ME, et al. . (1980) In vitro perifusion for the study of parathyroid hormone secretion: effects of extracellular calcium concentration and β-adrenergic regulation on bovine parathyroid hormone secretion in vitro. Calcif Tissue Int 32, 1927.CrossRefGoogle Scholar
22Hughes, MR, Brumbaugh, PF, Hussler, MR, et al. . (1975) Regulation of serum 1α,25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science 190, 578580.CrossRefGoogle Scholar
23Schedl, HP, Conway, T, Horst, RL, et al. . (1996) Effects of dietary calcium and phosphorus on vitamin D metabolism and calcium absorption in hamster. Proc Soc Exp Biol Med 211, 281286.CrossRefGoogle ScholarPubMed
24Vieth, R, Fraser, D & Kooh, SW (1987) Low dietary calcium reduces 25-hydroxycholecalciferol in plasma of rats. J Nutr 117, 914918.CrossRefGoogle ScholarPubMed
25Gascon-Barré, M, D'Amour, P, Dufresne, L, et al. . (1985) Interrelationships between circulating vitamin D metabolites in normocalciuric and hypercalciuric renal stone formers. Ann Nutr Metab 29, 289296.CrossRefGoogle ScholarPubMed
26Fleet, JC, Gliniak, C, Zhang, Z, et al. . (2008) Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice. J Nutr 138, 11141120.CrossRefGoogle ScholarPubMed
27Christakos, S, Dhawan, P, Liu, Y, et al. . (2003) New insights into the mechanisms of vitamin D action. J Cell Biochem 88, 695705.CrossRefGoogle ScholarPubMed
28Brown, AJ, Krits, I & Armbrecht, HJ (2005) Effect of age, vitamin D, and calcium on the regulation of rat intestinal epithelial calcium channels. Arch Biochem Biophys 437, 5158.CrossRefGoogle ScholarPubMed
29Wasserman, RH, Smith, CA, Brindak, ME, et al. . (1992) Vitamin D and mineral deficiencies increase the plasma membrane calcium pump of chicken intestine. Gastroenterology 102, 886894.CrossRefGoogle ScholarPubMed
30Fox, J, Bunker, JE, Kamimura, M, et al. . (1990) Low-calcium diets increase both production and clearance of 1,25-dihydroxyvitamin D3 in rats. Am J Physiol 258, E282E287.Google ScholarPubMed
31Goff, JP, Reinhardt, TA, Engstrom, GW, et al. . (1992) Effect of dietary calcium or phosphorus restriction and 1,25-dihydroxyvitamin D administration on rat intestinal 24-hydroxylase. Endocrinology 131, 101104.CrossRefGoogle ScholarPubMed
32Naveh-Many, T, Rahamimov, R, Livni, N, et al. . (1995) Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96, 17861793.CrossRefGoogle ScholarPubMed
33Brown, EM, Gamba, G, Riccardi, D, et al. . (1993) Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 366, 575580.CrossRefGoogle ScholarPubMed
34Chattopadhyay, N (2006) Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. Am J Physiol Endocrinol Metab 290, E761E770.CrossRefGoogle ScholarPubMed
35Díaz, R, El-Hajj, G & Brown, E (2000) Parathyroid hormone and poly hormones: production and export. In Handbook of Physiology: Endocrine Regulation of Water and Electrolyte Balance, pp. 607662 [Fray, Y, editor]. New York: Oxford University Press.Google Scholar
36Bas, S, Bas, A, López, I, et al. . (2005) Nutritional secondary hyperparathyroidism in rabbits. Domest Anim Endocrinol 28, 380390.CrossRefGoogle ScholarPubMed
37Brown, EM (1983) Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56, 572581.CrossRefGoogle ScholarPubMed
38Kanesaka, Y, Tokunaga, H, Iwashita, K, et al. . (2001) Endothelin receptor antagonist prevents parathyroid cell proliferation of low calcium diet-induced hyperparathyroidism in rats. Endocrinology 142, 407413.CrossRefGoogle ScholarPubMed
39Miao, D, Li, J, Xue, Y, et al. . (2004) Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice. Endocrinology 145, 35543562.CrossRefGoogle ScholarPubMed
40Zhang, Y, Lai, WP, Wu, CF, et al. . (2007) Ovariectomy worsens secondary hyperparathyroidism in mature rats during low-Ca diet. Am J Physiol Endocrinol Metab 292, E723E731.CrossRefGoogle ScholarPubMed
41Naveh-Many, T, Raue, F, Grauer, A, et al. . (1992) Regulation of calcitonin gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Bone Miner Res 7, 12331237.CrossRefGoogle ScholarPubMed
42Ferrari, S, Bonjour, JP & Rizzoli, R (1998) The vitamin D receptor gene and calcium metabolism. Trends Endocrinol Metab 9, 259265.CrossRefGoogle ScholarPubMed
43Tolosa de Talamoni, N, Mykkanen, H & Wasserman, R (1990) Enhancement of sulfhydryl groups availability in the intestinal brush border membrane by deficiencies of dietary calcium and phosphorus in chicks. J Nutr 120, 11981204.CrossRefGoogle ScholarPubMed
44Mykkanen, HM & Wasserman, RH (1989) Uptake of 75Se-selenite by brush border membrane vesicles from chick duodenum stimulated by vitamin D. J Nutr 119, 242247.CrossRefGoogle ScholarPubMed
45Benn, BS, Ajibade, D, Porta, A, et al. . (2008) Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 149, 31963205.CrossRefGoogle ScholarPubMed
46Kalkwarf, HJ, Khoury, JC & Lanphear, BP (2003) Milk intake during childhood and adolescence, adult bone density, and osteoporotic fractures in US women. Am J Clin Nutr 77, 1011.CrossRefGoogle ScholarPubMed
47Kasukawa, Y, Baylink, DJ, Wergedal, JE, et al. . (2003) Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice. Endocrinology 144, 46824689.CrossRefGoogle Scholar
48Steiner, PD, Forrer, R, Kneissel, M, et al. . (2001) Influence of a low calcium and phosphorus diet on the anabolic effect of human parathyroid hormone (1-38) in female rats. Bone 29, 344351.CrossRefGoogle ScholarPubMed
49Zheng, Y, Zhou, H, Modzelewski, JR, et al. . (2007) Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res 67, 95429548.CrossRefGoogle ScholarPubMed
50Bezerra, FF, Mendonça, LM, Lobato, EC, et al. . (2004) Bone mass is recovered from lactation to postweaning in adolescent mothers with low calcium intakes. Am J Clin Nutr 80, 13221326.CrossRefGoogle ScholarPubMed
51Bezerra, FF, Cabello, GM, Mendonça, LM, et al. . (2008) Bone mass and breast milk calcium concentration are associated with vitamin D receptor gene polymorphisms in adolescent mothers. J Nutr 138, 277281.CrossRefGoogle ScholarPubMed
52North American Menopause Society (2006) The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 13, 862877.CrossRefGoogle Scholar
53Papaioannou, A, Kennedy, CC, Ioannidis, G, et al. . (2009) The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20, 703714.CrossRefGoogle ScholarPubMed
54Mavroeidi, A, Stewart, AD, Reid, DM, et al. . (2009) Physical activity and dietary calcium interactions in bone mass in Scottish postmenopausal women. Osteoporos Int 20, 409416.CrossRefGoogle ScholarPubMed
55Murayama, A, Takeyama, K, Kitanaka, S, et al. . (1999) Positive and negative regulations of the renal 25-hydroxyvitamin D3 1α-hydroxylase gene by parathyroid hormone, calcitonin, and 1α,25(OH)2D3 in intact animals. Endocrinology 140, 22242231.CrossRefGoogle Scholar
56Omdahl, JL, Morris, HA & May, BK (2002) Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 22, 139166.CrossRefGoogle ScholarPubMed
57Anderson, PH, O'Loughlin, PD, May, BK, et al. . (2003) Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase-polymerase chain reaction. J Mol Endocrinol 31, 123132.CrossRefGoogle ScholarPubMed
58Kato, S, Takeyama, K, Kitanaka, S, et al. . (1999) In vivo function of VDR in gene expression-VDR knock-out mice. J Steroid Biochem Mol Biol 69, 247251.CrossRefGoogle ScholarPubMed
59Bajwa, A, Horst, RL & Beckman, MJ (2005) Gene profiling the effects of calcium deficiency versus 1,25-dihydroxyvitamin D induced hypercalcemia in rat kidney cortex. Arch Biochem Biophys 438, 182194.CrossRefGoogle ScholarPubMed
60Pizzato, AC & Barros, EJ (2003) Dietary calcium intake among patients with urinary calculi. Nutr Res 23, 16511660.CrossRefGoogle Scholar
61Pasch, A, Frey, FJ, Eisenberger, U, et al. . (2008) PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Nephrol Dial Transplant 23, 25632570.CrossRefGoogle ScholarPubMed
62MacDonald, HB (2008) Dairy nutrition: what we knew then to what we know now. Int Dairy J 18, 774777.CrossRefGoogle Scholar
63Zemel, MB (2005) The role of dairy foods in weight management. J Am Coll Nutr 24, 537S546S.CrossRefGoogle ScholarPubMed
64Mirmiran, P, Azadbakht, L & Azizi, F (2005) Dietary quality-adherence to the dietary guidelines in Tehranian adolescents: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res 75, 195200.CrossRefGoogle Scholar
65Jones, BH, Kim, JH, Zemel, MB, et al. . (1996) Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. Am J Physiol 270, E192E196.Google ScholarPubMed
66Xue, B, Moustaid, N, Wilkison, WO, et al. . (1998) The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism. FASEB J 12, 13911396.CrossRefGoogle Scholar
67Zemel, MB, Shi, H, Greer, B, et al. . (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 11321138.CrossRefGoogle ScholarPubMed
68Major, GC, Chaput, JP, Ledoux, M, et al. . (2008) Recent developments in calcium-related obesity research. Obes Rev 9, 428445.CrossRefGoogle ScholarPubMed
69Fujita, T & Palmieri, GM (2000) Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 18, 109125.CrossRefGoogle ScholarPubMed
70Xue, B, Greenberg, AG, Kraemer, FB, et al. . (2001) Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J 15, 25272529.CrossRefGoogle ScholarPubMed
71Lambert, JR, Young, CD, Persons, KS, et al. . (2007) Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cells. Biochem Biophys Res Commun 361, 189195.CrossRefGoogle ScholarPubMed
72Tolosa de Talamoni, N, Narvaez, CJ & Welsh, JE (2004) Menadione potentiates the oxidative stress produced by 1,25(OH)2D3 on breast cancer cells. In Proceedings of the XII Biennial Meeting of the Society for Free Radical Research International, Buenos Aires, Argentina, pp. 201205 [Puntarulo, S and Boveris, A, editors]. Bologna, Italy: Medimond.Google Scholar
73Sun, X & Zemel, MB (2004) Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J Nutr 134, 30543060.CrossRefGoogle ScholarPubMed
74Prins, JB, Walker, NI, Winterford, CM, et al. . (1994) Human adipocyte apoptosis occurs in malignancy. Biochem Biophys Res Commun 205, 625630.CrossRefGoogle ScholarPubMed
75Della-Fera, MA, Qian, H & Baile, CA (2001) Adipocyte apoptosis in the regulation of body fat mass by leptin. Diabetes Obes Metab 3, 299310.CrossRefGoogle ScholarPubMed
76Morris, KL & Zemel, MB (2005) 1,25-Dihydroxyvitamin D3 modulation of adipocyte glucocorticoid function. Obes Res 13, 670677.CrossRefGoogle ScholarPubMed
77Loos, RJ, Rankinen, T, Leon, AS, et al. . (2004) Calcium intake is associated with adiposity in black and white men and white women of the HERITAGE Family Study. J Nutr 134, 17721778.CrossRefGoogle ScholarPubMed
78Jackmain, M, Doucet, E, Despres, J, et al. . (2003) Calcium intake, body composition and lipoprotein-lipid concentrations in adults. Am J Clin Nutr 77, 14481452.CrossRefGoogle Scholar
79Barr, S (2003) Increased dairy product or calcium intake: is body weight or composition affected in humans? J Nutr 133, 245S248S.CrossRefGoogle ScholarPubMed
80Heiss, CJ, Shaw, SE & Carothers, L (2008) Association of calcium intake and adiposity in postmenopausal women. J Am Coll Nutr 27, 260266.CrossRefGoogle ScholarPubMed
81Addison, WLT & Clark, HG (1924) Calcium and potassium chlorides in the treatment of arterial hypertension. Can Med Assoc J 15, 913915.Google Scholar
82Crawford, MD, Gardner, MJ & Morris, JN (1968) Mortality and hardness of local water supplies. Lancet 20, 827831.CrossRefGoogle Scholar
83McCarron, DA, Morris, CD & Cole, C (1982) Dietary calcium in human hypertension. Science 217, 267269.CrossRefGoogle ScholarPubMed
84McCarron, DA, Morris, CD & Stanton, JL (1984) Hypertension and calcium. Science 226, 386393.CrossRefGoogle ScholarPubMed
85Bucher, HC, Guyatt, GH, Cook, RJ, et al. . (1996) Effect of calcium suplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 275, 11131117.CrossRefGoogle Scholar
86Griffith, LE, Guyatt, GH, Cook, RJ, et al. . (1999) The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens 12, 8492.CrossRefGoogle ScholarPubMed
87Resnick, LM (1999) The role of dietary calcium in hypertension: a hierarchical overview. Am J Hypertens 12, 99112.CrossRefGoogle ScholarPubMed
88Zemel, MB (1994) Dietary calcium, calcitrophic hormones and hypertension. Nutr Metab Cardiovasc Dis 4, 224228.Google Scholar
89Appel, LJ, Moore, TJ, Obarzanek, E, et al. . (1997) A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336, 11171124.CrossRefGoogle ScholarPubMed
90Wang, L, Manson, JE, Buring, JE, et al. . (2008) Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 51, 10731079.CrossRefGoogle ScholarPubMed
91Alonso, A, Beunza, JJ, Delgado-Rodríguez, M, et al. . (2005) Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr 82, 972979.CrossRefGoogle Scholar
92Vyas, HK & Tong, PS (2003) Process for calcium retention during skim milk ultrafiltration. J Dairy Sci 86, 27612766.CrossRefGoogle ScholarPubMed
93FitzGerald, RJ, Murray, BA & Walsh, DJ (2004) Hypotensive peptides from milk proteins. J Nutr 134, 980S988S.CrossRefGoogle ScholarPubMed
94Weiss, D & Taylor, WR (2008) Deoxycorticosterone acetate salt hypertension in apolipoprotein E− / −  mice results in accelerated atherosclerosis: the role of angiotensin II. Hypertension 51, 218224.CrossRefGoogle ScholarPubMed
95Ramón de Berrazueta, J (1999) The role of calcium in the regulation of normal vascular tone and in arterial hypertension. Rev Esp Cardiol 52, 2533.Google ScholarPubMed
96Scholz-Ahrens, KE & Schrezenmeir, J (2006) Milk minerals and the metabolic syndrome. Int Dairy J 16, 13991407.CrossRefGoogle Scholar
97Szollosi, A, Nenquin, M, Aguilar-Bryan, L, et al. . (2006) Glucose stimulates Ca2+ influx and insulin secretion in 2-week-old β-cells lacking ATP-sensitive K+ channels. J Biol Chem 282, 17471756.CrossRefGoogle ScholarPubMed
98Myers, VH & Champagne, CM (2007) Nutritional effects on blood pressure. Curr Opin Lipidol 18, 2024.CrossRefGoogle ScholarPubMed
99Ryan-Harshman, M & Aldoori, W (2007) Diet and colorectal cancer: review of the evidence. Can Fam Physician 53, 19131920.Google ScholarPubMed
100Holt, PR, Atillasoy, EO, Gilman, J, et al. . (1998) Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 280, 10741079.CrossRefGoogle ScholarPubMed
101McCullough, ML, Robertson, AS, Rodriguez, C, et al. . (2003) Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 14, 112.CrossRefGoogle ScholarPubMed
102Terry, P, Baron, JA, Bergkvist, L, et al. . (2002) Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer 43, 3946.CrossRefGoogle ScholarPubMed
103Pietinen, P, Malila, N, Virtanen, M, et al. . (1999) Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control 10, 387396.CrossRefGoogle Scholar
104Järvinen, R, Knekt, P, Hakulinen, T, et al. . (2001) Prospective study on milk products, calcium and cancers of the colon and rectum. Eur J Clin Nutr 55, 10001007.CrossRefGoogle ScholarPubMed
105Hofstad, B, Almendingen, K, Vatn, M, et al. . (1998) Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 59, 148156.CrossRefGoogle ScholarPubMed
106Grau, MV, Baron, JA, Sandler, RS, et al. . (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95, 17651771.CrossRefGoogle ScholarPubMed
107Marcus, PM & Newcomb, PA (1998) The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin women. Int J Epidemiol 27, 788793.CrossRefGoogle ScholarPubMed
108Franceschi, S & Favero, A (1999) The role of energy and fat in cancers of the breast and colon-rectum in a southern European population. Ann Oncol 6, 6163.CrossRefGoogle Scholar
109Levi, F, Pasche, C, Lucchini, F, et al. . (2000) Selected micronutrients and colorectal cancer. a case–control study from the canton of Vaud, Switzerland. Eur J Cancer 36, 21152119.CrossRefGoogle ScholarPubMed
110Pritchard, RS, Baron, JA & Gerhardsson de Verdier, M (1996) Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev 5, 897900.Google ScholarPubMed
111Cho, E, Smith-Warner, SA, Spiegelman, D, et al. . (2004) Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 96, 10151022.CrossRefGoogle ScholarPubMed
112Park, SY, Murphy, SP, Wilkens, LR, et al. . (2007) Calcium and vitamin D intake and risk of colorectal cancer: the Multiethnic Cohort Study. Am J Epidemiol 165, 784793.CrossRefGoogle ScholarPubMed
113Wallace, K, Baron, JA, Cole, BF, et al. . (2004) Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 96, 921925.CrossRefGoogle ScholarPubMed
114Shaukat, A, Scouras, N & Schünemann, HJ (2005) Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials. Am J Gastroenterol 100, 390394.CrossRefGoogle ScholarPubMed
115Bises, G, Bajna, E, Manhardt, T, et al. . (2007) Gender-specific modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon. J Nutr 137, 211S215S.CrossRefGoogle ScholarPubMed
116Pele, LC, Thoree, V, Mustafa, F, et al. . (2007) Low dietary calcium levels modulate mucosal caspase expression and increase disease activity in mice with dextran sulfate sodium induced colitis. J Nutr 137, 24752480.CrossRefGoogle ScholarPubMed
117Hobson, SA, Wright, J, Lee, F, et al. . (2003) Activation of the MAP kinase cascade by exogenous calcium-sensing receptor. Mol Cell Endocrinol 200, 189198.CrossRefGoogle ScholarPubMed
118Chakrabarty, S, Radjendirane, V, Appelman, H, et al. . (2003) Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of β-catenin/TCF activation. Cancer Res 63, 6771.Google ScholarPubMed
119Farrow, DC & Davis, S (1990) Diet and the risk of pancreatic cancer in men. Am J Epidemiol 132, 423431.CrossRefGoogle ScholarPubMed
120Kemmis, CM & Welsh, J (2008) Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem 105, 980988.CrossRefGoogle ScholarPubMed
121Mordan-McCombs, S, Brown, T, Zinser, G, et al. . (2007) Dietary calcium does not affect prostate tumor progression in LPB-Tag transgenic mice. J Steroid Biochem Mol Biol 103, 747751.CrossRefGoogle Scholar
122Baron, JA, Beach, M, Wallace, K, et al. . (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14, 586589.CrossRefGoogle Scholar
123Torniainen, S, Hedelin, M, Autio, V, et al. . (2007) Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland. Cancer Epidemiol Biomarkers Prev 16, 956961.CrossRefGoogle ScholarPubMed
124Bonjour, JP, Chevalley, T & Fardellone, P (2007) Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer. Br J Nutr 97, 611616.CrossRefGoogle ScholarPubMed
125Xue, L, Yang, K, Newmark, H, et al. . (1996) Epithelial cell hyperproliferation induced in the exocrine pancreas of mice by a Western-style diet. J Natl Cancer Inst 88, 15861590.CrossRefGoogle ScholarPubMed
126Skinner, HG, Michaud, DS, Giovannucci, E, et al. . (2006) Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 15, 16881695.CrossRefGoogle ScholarPubMed
127Stolzenberg-Solomon, RZ, Vieth, R, Azad, A, et al. . (2006) A prospective nested case–control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66, 1021310219.CrossRefGoogle ScholarPubMed
128Stolzenberg-Solomon, RZ, Hayes, RB, Horst, RL, et al. . (2009) Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 69, 14391447.CrossRefGoogle ScholarPubMed
129Cramer, DW (1989) Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am J Epidemiol 130, 904910.CrossRefGoogle ScholarPubMed
130Goodman, MT, Wu, AH, Tung, KH, et al. . (2002) Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 156, 148157.CrossRefGoogle ScholarPubMed
131Kuokkanen, M, Butzow, R, Rasinperä, H, et al. . (2005) Lactase persistence and ovarian carcinoma risk in Finland, Poland and Sweden. Int J Cancer 117, 9094.CrossRefGoogle ScholarPubMed
132Fung, WL, Risch, H, McLaughlin, J, et al. . (2003) The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 12, 678680.Google Scholar
133Qin, LQ, Xu, JY, Wang, PY, et al. . (2005) Milk/dairy products consumption, galactose metabolism and ovarian cancer: meta-analysis of epidemiological studies. Eur J Cancer Prev 14, 1319.CrossRefGoogle ScholarPubMed
134Mommers, M, Schouten, LJ, Goldbohm, RA, et al. . (2006) Dairy consumption and ovarian cancer risk in The Netherlands Cohort Study on Diet and Cancer. Br J Cancer 94, 165170.CrossRefGoogle ScholarPubMed
135Genkinger, JM, Hunter, DJ, Spiegelman, D, et al. . (2006) Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 15, 364372.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 A diet poor in Ca2+ decreases serum Ca2+ levels, which can be accompanied by normal or low serum phosphate. Hypocalcaemia induces a high parathyroid hormone (PTH) secretion, which in turn promotes renal 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) synthesis. This hormone binds to vitamin D receptors (VDR) in the intestine triggering transient receptor potential cation channel, subfamily V, member 6 (TRPV6), calbindin D (CB), Ca2+ pump (PMCA1), Na+/Ca2+ exchanger (NCX1) and alkaline phosphatase synthesis. As a consequence, the efficiency of intestinal Ca absorption is enhanced. VDRE, vitamin D response element; RXR, retinoid X receptor.

Figure 1

Fig. 2 Metabolic changes caused by low-Ca2+ diets on different organs and tissues. TRPV6, transient receptor potential cation channel, subfamily V, member 6; VDR, vitamin D receptor; PTH, parathyroid hormone; NP, normal phosphate; CYP27B1, 25-OH-cholecalciferol 1-hydroxylase; 1,25(OH)2D3, 1,25-dihydroxyvitamin D3.